Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome’s effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017–2018
PLOS ONE · 23.02.2024 · 19 (2) · e0298662
DOI: 10.1371/journal.pone.0298662 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS ONE, online erschienen am 23.02.2024. Verfasst von Rebeca Garazi Elguezabal Rodelo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Puebla, México. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Metabolic Syndrome. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Programa para el Desarrollo Profesional Docente, Vicerrectoría de Investigación y Estudios de Posgrado, Benemérita Universidad Autónoma de Puebla.
Abstract (Originalsprache)
Background
The aim was to evaluate the effect different types of abdominal fat have on NAFLD development and the effects of abdominal fat has on the association between Metabolic Syndrome (MetS) and NALFD.
Methods
Data was collected from the cross-sectional NHANES dataset (2017–2018 cycle). Using the controlled attenuation parameter (USG CAP, dB/m), which measures the level of steatosis, the cohort was stratified into two groups: NAFLD(+) (≥274 dB/m) and NAFLD(-). Using complex samples analyses, associations between liver steatosis or NAFLD and types of abdominal fat area [Total abdominal (TAFA), subcutaneous (SAT), and visceral (VAT)] were determined. Pearson’s correlation coefficient (r) was calculated to evaluate the associations between adipose tissues and NAFLD. Logistic regression was used to determine the risk [odds ratio (OR) and 95% confidence interval (95%CI)]. Participants were also classified by MetS, using the Harmonizing Definition criteria.
Results
Using 1,980 participants (96,282,896 weighted), there was a significant (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Puebla, México.
- Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
ORCID-Profile: Esther López-Bayghen
Förderung
- Programa para el Desarrollo Profesional Docente
- Vicerrectoría de Investigación y Estudios de Posgrado, Benemérita Universidad Autónoma de Puebla
Zitieren
APA
Elguezabal Rodelo, R. G., Porchia, L. M., Torres-Rasgado, E., López-Bayghen, E., & Gonzalez-Mejia, M. E. (2024). Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome’s effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017–2018. PLOS ONE, 19(2), e0298662. https://doi.org/10.1371/journal.pone.0298662
Vancouver
Elguezabal Rodelo RG, Porchia LM, Torres-Rasgado E, López-Bayghen E, Gonzalez-Mejia ME. Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome’s effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017–2018. PLOS ONE. 2024;19(2):e0298662. doi:10.1371/journal.pone.0298662
BibTeX
@article{ElguezabalRodelo2024,
author = {Elguezabal Rodelo, Rebeca Garazi and Porchia, Leonardo M and Torres-Rasgado, Enrique and López-Bayghen, Esther and Gonzalez-Mejia, M Elba},
title = {Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome’s effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017–2018},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {2},
pages = {e0298662},
doi = {10.1371/journal.pone.0298662}
}
EUVIMED